GPT and liposarcoma: The RNA-based TMM predictors were further tested on a previously published external cohort of cell lines and mesenchymal stem cells (n = 14) and on liposarcoma tumor tissue samples (n = 18), which were assigned TMM classifications using TA and ALT assays21,22.